CEO SUMMARY: Biggest deal in recent weeks was the $1.55 billion Beckman Coulter paid to acquire BioSite and its Triage BNP test. But the most interesting news may be the entry of 3M Corporation into clinical diagnostics, based on its acquisition of Acolyte Biomedica Ltd., a company which offers a five-hour rapid culture-based MRSA test. […]
Lots of IVD Acquisitions as Buyers Spend Money
Slew of deals and the variety of buyers reveal a strong demand for molecular diagnostics firms
- By Robert Michel
- > From the Volume XIV No. 5 - April 2, 2007 Issue
- Tags: aco, cap, diagnostics industry, genome sequencing, imaging pathology, in vitro diagnostic, in vitro diagnostics, in vitro diagnostics industry, ivd industry, lab test, lab testing, laboratories, management systems, medical diagnostic, molecular diagnostic, pathologists, pathology imaging, roche diagnostic, roche diagnostics
